Huvepharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Huvepharma

Access the complete profile.

Huvepharma Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	311111 Dog & Cat Food Manufacturing
Address	525 Westpark Peachtree City, GA 30269

Note: Revenues for privately held companies are statistical evaluations.


Huvepharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Huvepharma's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Huvepharma is classified as operating in the Dog & Cat Food Manufacturing industry, NAICS Code 311111.

Huvepharma Annual Revenue and Growth Rate

Huvepharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Huvepharma's revenues are gauged from an analysis of company filings.

Huvepharma's Income Statement (based on Industry Averages)

Huvepharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Huvepharma is developing and marketing. Huvepharma doesn't have any recent trademark applications, indicating Huvepharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CLARITY-Q Flavorings for animal feed being plant extracts for use in the manufacturing of animal feed	11/19/2021
PRIMELINE Veterinary vaccines for bovines	04/27/2021
TERMI-FLY Veterinary preparations, namely, insecticides, larvicides; Veterinary preparations, namely, insect growth regulators for commercial and domestic use, insect growth regulators for use to control ectoparasites, and insect growth regulators for use to control flies	10/13/2020

See all trademarks and details in the Full Report.

Market Share of Huvepharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Huvepharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PEDIGREE OVENS	Harvard, IL	100
FAIRVIEW MILLS	Seneca, KS	82
KELLY FOODS	Berlin, MD	63
INDIGO WILD	Kansas City, MO	55
GERHARDI	Montgomery, AL	50
KMIN USA	Valley, AL	48
BOUDREAUX OPERATING AQUISITIONS	Maumelle, AR	37
OLLIE PETS	New York, NY	31
NUTRIPACK	Markham, IL	29

Nearby Competitors

These companies are similar in business line and location to Huvepharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
HUVEPHARMA	Peachtree City, GA	100
NORAX SUPPLEMENTS	Newnan, GA	22
KABOBS ACQUISITION	Lake City, GA	17
TOLUCA FOODS	Morrow, GA	17
CALPIS AMERICA	Peachtree City, GA	14
TERMINUS TRADING & PROVISIONS INC. D/B/A REVERE MEAT	Forest Park, GA	14
ARKO VEAL	Forest Park, GA	9
SEASON ALL FLOWER SHOP	Jonesboro, GA	3
215 PHILLY EATS	Mcdonough, GA	1
FOOD MASTERS	Griffin, GA	0

Future Competition: Huvepharma's Fastest Growing Competitors

These companies are in the same general field as Huvepharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)